Chongyu Su
- Cancer Research top 10%
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Cancer Genomics and Diagnostics 2
- Infectious Diseases top 10%
-
- RNA modifications and cancer 2
- Cancer-related gene regulation 2
-
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 2
-
- Lung Cancer Diagnosis and Treatment 3
- Journals
- Frontiers in Oncology (1 paper)Nature Communications (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- China
In The Last Decade
Chongyu Su
14 papers receiving 518 citations
Peers
Comparison fields: 5 of 103
- Cancer Research 167
- Infectious Diseases 144
- Molecular Biology 219
- Health Informatics 4
- Immunology 58
Countries citing papers authored by Chongyu Su
This map shows the geographic impact of Chongyu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongyu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongyu Su more than expected).
Fields of papers citing papers by Chongyu Su
This network shows the impact of papers produced by Chongyu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongyu Su. The network helps show where Chongyu Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chongyu Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2021 | 8 | |
| 3 | 2021 | 4 | |
| 4 | 2020 | 224 | |
| 5 | 2019 | 61 | |
| 6 | 2018 | 108 | |
| 7 | 2018 | 41 | |
| 8 | 2018 | 10 | |
| 9 | Cholecystokinin attenuates radiation-induced lung cancer cell apoptosis by modulating p53 gene transcription. | 2017 | 5 |
| 10 | 2016 | 1 | |
| 11 | 2015 | 9 | |
| 12 | 2014 | 13 | |
| 13 | 2013 | 32 | |
| 14 | 2013 | 6 |
About Chongyu Su
Chongyu Su is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 526 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (167 citations), Infectious Diseases (144 citations) and Molecular Biology (219 citations). Chongyu Su has collaborated with scholars based in China. Frequent co-authors include Daping Yu, Yi Han, Xiaoyun Song, Zhidong Liu, Ning Xiao, Shijie Zhou, Xiaoqing Cao, Yunsong Li, Taijiao Jiang and Huijuan Wang. Their work appears in journals such as Frontiers in Oncology, Nature Communications, Journal of Cellular Physiology, Cancer Medicine and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.